Pharmacogenomic strategies in drug safety
21 September 2011
Download Type: Adobe PDF
This review highlights some successes in discovery and translation of pharmacogenomic biomarkers for adverse drug events and outlines future strategies to optimize the development and clinical application of pharmacogenomic information.
Drug safety is a priority for drug developers and regulatory agencies. Pharmacogenomics is a powerful tool that can be used to manage clinical risks as well as resolve the mechanistic basis of adverse drug events.